Physician profile
Todd Johnson
NPI 1902856479
$1,303.94
in general payments reported to CMS, 2019-2025
16 companies · $52.19 in 2025
The $52.19 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $128 · 2021: $436 · 2022: $449 · 2023: $30.90 · 2025: $52.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $543.73 | 2021-2022 | |
| Pacira Therapeutics, INC. | $162.43 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $149.06 | 2019-2021 | |
| Bioventus LLC | $72.63 | 2022 | |
| Ferring Pharmaceuticals INC. | $68.47 | 2019-2021 | |
| Horizon Therapeutics Plc | $55.68 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $49.89 | 2019 | |
| Orthofix Medical, INC. | $38.00 | 2020-2021 | |
| Pylant Medical | $31.68 | 2023-2025 | |
| Trice Medical, INC. | $26.25 | 2019 | |
| Medtronic USA, INC. | $20.98 | 2019 | |
| Kci USA, INC. | $18.77 | 2021 | |
| Organon LLC | $18.62 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.77 | 2023 | Seglentis |
| Ethicon US, LLC | $16.02 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $14.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.